Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dapsone-induced peripheral neuropathy.

W C Koller, L K Gehlmann, F D Malkinson

    Archives of Neurology
    |October 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Contamination of Bactericidal Agents.

    Canadian Medical Association journal·2010
    Same author

    Subthalamic deep brain stimulation and impulse control in Parkinson's disease.

    European journal of neurology·2009
    Same author

    A comparison of Parkinson's disease symptoms and self-reported functioning and well being.

    Parkinsonism & related disorders·2008
    Same author

    Topiramate in essential tremor: a double-blind, placebo-controlled trial.

    Neurology·2006
    Same author

    Apolipoprotein E controls the risk and age at onset of Parkinson disease.

    Neurology·2004
    Same author

    Advances in the treatment of Parkinson's disease.

    Drugs of today (Barcelona, Spain : 1998)·2004
    Same journal

    Incorrect Table Entries and Word.

    Archives of neurology·2016
    Same journal

    IDEAL for CCSVI Research-Reply.

    Archives of neurology·2013
    Same journal

    Atlas of Inherited Metabolic Diseases, 3rd ed.

    Archives of neurology·2013
    Same journal

    Error in byline: in heterogeneity of coenzyme q10 deficiency: patient study and literature review.

    Archives of neurology·2013
    Same journal

    This month in archives of neurology.

    Archives of neurology·2013
    Same journal

    About this journal.

    Archives of neurology·2013
    See all related articles

    Dapsone therapy can rarely cause peripheral neuropathy, primarily affecting motor function. This condition typically resolves after discontinuing the drug, as seen in a patient with slow acetylator metabolism.

    Area of Science:

    • Neurology
    • Pharmacology
    • Toxicology

    Background:

    • Dapsone is a medication used to treat various conditions, including leprosy and dermatitis herpetiformis.
    • Peripheral neuropathy is a known but rare adverse effect of dapsone therapy.
    • The neurotoxic effects of dapsone are not fully understood, but altered drug metabolism may play a role.

    Observation:

    • A patient developed significant motor deficits and loss of vibration sense after starting a low dose of dapsone.
    • The patient was identified as a slow acetylator of isoniazid, suggesting a similar metabolic profile for dapsone.
    • Neurological symptoms improved rapidly upon dapsone discontinuation.

    Findings:

    • Dapsone-induced peripheral neuropathy can manifest as motor deficits and sensory disturbances.

    Related Experiment Videos

  • Slow acetylator status may increase the risk of dapsone neurotoxicity.
  • Metabolic factors likely influence the development and severity of dapsone-induced neuropathy.

    • Implications:

    • Clinicians should be vigilant for peripheral neuropathy in patients receiving dapsone, especially those with slow acetylator phenotypes.
    • Understanding the metabolic pathways of dapsone is crucial for predicting and preventing neurotoxicity.
    • Further research into the mechanisms of dapsone neurotoxicity could lead to safer therapeutic strategies.